Alambic Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-13,616
| Closed | -$402K | – | 412 |
|
|
2018
Q1 | $402K | Sell |
13,616
-89,600
| -87% | -$2.65M | 0.06% | 343 |
|
|
2017
Q4 | $3.55M | Sell |
103,216
-8,345
| -7% | -$287K | 0.43% | 80 |
|
|
2017
Q3 | $4.04M | Sell |
111,561
-2,100
| -2% | -$76K | 0.44% | 71 |
|
|
2017
Q2 | $2.94M | Buy |
113,661
+16,400
| +17% | +$424K | 0.36% | 76 |
|
|
2017
Q1 | $1.87M | Buy |
97,261
+41,200
| +73% | +$791K | 0.23% | 151 |
|
|
2016
Q4 | $935K | Buy |
56,061
+21,500
| +62% | +$359K | 0.17% | 205 |
|
|
2016
Q3 | $711K | Buy |
34,561
+23,111
| +202% | +$475K | 0.17% | 213 |
|
|
2016
Q2 | $350K | Buy |
11,450
+2,250
| +24% | +$68.8K | 0.09% | 353 |
|
|
2016
Q1 | $344K | Buy |
+9,200
| New | +$344K | 0.11% | 291 |
|